Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.

Patient Relat Outcome Meas · 2011 · PMC3417933 · PMID 22915978

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Although none of these trials, other than CLOT, demonstrated statistically significant differences between LMWHs and warfarin, there was a strong trend favoring LMWHs in all the studies.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.